Zobrazeno 1 - 10
of 10
pro vyhledávání: '"P. V. Krivorot'ko"'
Autor:
I. Е. Tyurin, N. I. Rozhkova, E. V. Artamonova, E. A. Busko, V. V. Didenko, A. D. Zikiryakhodzhaev, M. S. Karpova, G. Е. Kvetenadze, P. V. Krivorot’ko, M. L. Mazo, A V. Petrovsky, О. S. Puchkova, S. V. Serebryakova, А. P. Bakulev
Publikováno v:
Вестник рентгенологии и радиологии, Vol 105, Iss 2, Pp 48-57 (2024)
Оn March 27, 2023, а multidisciplinary Advisory Board meeting was held in Moscow with the participation of Е.V. Artamonova, Е.А. Busko, V.V. Didenko, А.D. Zikiryakhodzhaev, М.S. Karpova, G.Е. Kvetenadze, P.V. Krivorot’ko, М.L. Mazo, А.V.
Externí odkaz:
https://doaj.org/article/7963af68720e47c9b598c9c18c40cbaa
Autor:
V. О. Bashlyk, V. F. Semiglazov, A. G. Kudaybergenova, A. S. Artem’eva, T. Yu. Semiglazova, V. S. Chirskiy, A. V. Komyakho, P. V. Krivorot’ko, V. V. Klimenko, Sh. M. Khadzhimatova, A. I. Tseluyko, S. S. Ereschenko
Publikováno v:
Опухоли женской репродуктивной системы, Vol 14, Iss 1, Pp 12-19 (2018)
Complete clinical response (determined by palpation, instrumental methods, and macroscopic examination) does not always imply the achievement of pathologic complete response. Correlation coefficient between complete clinical and complete pathologic r
Externí odkaz:
https://doaj.org/article/93f7eb5ed98e4383b1d0c89035e85d4e
Autor:
E. A. Bus’ko, A. V. Mishchenko, V. V. Semiglazov, P. V. Krivorot’ko, T. Yu. Semiglazova, R. M. Paltuev, A. S. Petrova, A. V. Komyakhov, V. F. Semiglazov
Publikováno v:
Опухоли женской репродуктивной системы, Vol 12, Iss 4, Pp 25-31 (2017)
The article presents the data on capability of sonoelastography for the evaluation of neoadjuvant chemotherapy effectiveness in breast cancer. Qualitative and quantitative changes of the strain ratio correlate with the degree of pathological regressi
Externí odkaz:
https://doaj.org/article/41e6d588c0644be99a0d4e01ead70f14
Autor:
G. A. Dashyan, V. F. Semiglazov, P. V. Krivorot’ko, T. Yu. Semiglazova, E. E. Topuzov, R. M. Paltuev, K. Yu. Zernov, V. S. Apollonova, S. S. Ereshchenko, A. V. Petrova, E. K. Zhil’tsova, O. A. Ivanova
Publikováno v:
Опухоли женской репродуктивной системы, Vol 12, Iss 1, Pp 46-51 (2016)
Brain metastases are detectable in 25–35 % of patients with progressive HER-2-positve breast cancer. Even after spreading metastases into the brain, chemotherapy in combination with anti-HER- 2 therapy improves survival due to better control of the
Externí odkaz:
https://doaj.org/article/df195e60b5004d29b0a2524764f3d9a8
Autor:
G. A. Dashyan, V. F. Semiglazov, P. V. Krivorot’ko, R. M. Paltuev, E. E. Topuzov, T. Yu. Semiglazova, E. K. Zhil’tsova, R. V. Donskikh, T. T. Tabagua, V. S. Apollonova
Publikováno v:
Опухоли женской репродуктивной системы, Vol 11, Iss 4, Pp 46-52 (2015)
As is known, the HER-2-expressing biological subtype of breast cancer (BC) is characterized by an aggressive course and has a poorprognosis in the absence of specific treatment. Before the emergence of trastuzumab, 5-year overall survival in patients
Externí odkaz:
https://doaj.org/article/af3e095f924344fdb4f749e144760fb4
Autor:
V F Semiglazov, E K Zhil'tsova, V V Semiglazov, V G Ivanov, G A Dashyan, A A Klettsel', A A Bozhok, K S Nurgaziev, E E Topuzov, P V Krivorot'ko, E V Tsyrlina, L M Bershteyn
Publikováno v:
Современная онкология, Vol 5, Iss 4, Pp 154-156 (2003)
Аримидекс (анастрозол) является более эффективным , чем тамоксифен или комбинация аримидекса (анастрозол) с тамоксифеном, в неоадъювант
Externí odkaz:
https://doaj.org/article/ec9dec3887e245a2879ec62d1bb70170
Autor:
V F, Semiglazov, V V, Semiglazov, P M, Paltuev, G A, Dashian, R V, Donskikh, A V, Komiakhov, P V, Krivorot'ko, K S, Nikolaev, I V, Nikitina, T Iu, Semiglazova
Publikováno v:
Voprosy onkologii. 60(1)
A decision regarding adjuvant chemotherapy in early (operable) breast cancer in the past was made entirely on the basis of clinical and pathological features. However with the growing awareness of tumor biology and the possibility of the genomic anal
Autor:
P V, Krivorot'ko
Publikováno v:
Voprosy onkologii. 59(1)
The aim of the study was to compare accuracy of conventional mammography and mammoscintigraphy with the 99mTc-Technetril in the detection of multicentric (MC) breast cancer. A total of 135 women (mean age 52 years) with unilateral simple breast lesio
Autor:
G A, Dashian, V F, Semiglazov, V V, Semiglazov, É É, Topuzov, P V, Krivorot'ko, R V, Donskikh, T T, Tabagua, I A, Grechukhina, Ts S, Dzhukaeva
Publikováno v:
Voprosy onkologii. 57(5)
Autor:
V F, Semiglazov, V V, Semiglazov, G A, Dashian, E K, Zhil'tsova, V G, Ivanov, A A, Bozhok, E E, Tonuzov, R M, Paltuev, O A, Mel'nikova, A A, Klettsel', P V, Krivorot'ko, R V, Donskikh, I A, Kochetova, A O, Damenia, K Iu, Zernov, D A, Voskresenskiĭ, L M, Bershteĭn
Publikováno v:
Voprosy onkologii. 53(4)
Data are presented on a randomized study (stage II) which was undertaken to assess the efficacy of neoadjuvant chemotherapy (doxorubicin+paclitaxel) vis-a-vis endocrine therapy with aromatase inhibitors (anastrazole or exemestane) in postmenopausal w